• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌对尿酸水平的影响:亚组分析和Meta回归的Meta分析

Effect of Probiotics on Uric Acid Levels: Meta-Analysis with Subgroup Analysis and Meta-Regression.

作者信息

Othman Rym Ben, Sassi Mouna Ben, Hammamia Syrine Ben, Dziri Chadli, Zanina Youssef, Salem Kamel Ben, Jamoussi Henda

机构信息

Institut National de Nutrition et de Technologie Alimentaire de Tunis, 11 Rue Jbal Lakhdhar, Tunis 1007, Tunisia.

Faculty of Medicine of Tunis, University of Tunis El Manar, 13 Rue Jbal Lakhdhar, Tunis 1007, Tunisia.

出版信息

Nutrients. 2025 Jul 29;17(15):2467. doi: 10.3390/nu17152467.

DOI:10.3390/nu17152467
PMID:40806052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12348837/
Abstract

BACKGROUND

Probiotics can modulate the microbiota and decrease uric acid levels.

OBJECTIVES

This meta-analysis aimed to assess the effects of probiotics on uric acid levels.

METHODS

The keywords "probiotics", "uric acid", "gout", "hyperuricemia" were searched in PubMed Medline, EMBASE, Web of Science, and Google Scholar. The search was limited to the English, French, Italian, and Spanish languages, and to the period between 1 January 2000 to 30 August 2024. We included RCTs and observational studies comparing probiotics to placebo. We excluded studies reporting (1) prebiotics, symbiotics, or postbiotics, (2) animal studies, and (3) case reports, commentaries, or reviews. Two independent reviewers performed quality assessment and data extraction. This meta-analysis was performed according to the PRISMA 2020 and AMSTAR 2 guidelines. The main outcome measure was uric acid levels "after-before" probiotic versus placebo interventions. Forest plots summarized the data using a random model.

RESULTS

Nine studies included 394 patients, of whom 201 were treated with probiotics and 193 with placebo. There was a statistically significant difference in favor of the probiotic group compared with the control group regarding the main outcome measure. However, substantial heterogeneity was noted, explained (after applying subgroup analysis and meta-regression) by the following moderators: continent, diseased/healthy, male sex, and monostrain probiotics.

CONCLUSIONS

This meta-analysis demonstrates that probiotics reduced uric acid levels in Asian males who had disease and were treated with monostrain probiotics.

摘要

背景

益生菌可调节微生物群并降低尿酸水平。

目的

本荟萃分析旨在评估益生菌对尿酸水平的影响。

方法

在PubMed Medline、EMBASE、科学网和谷歌学术中搜索关键词“益生菌”“尿酸”“痛风”“高尿酸血症”。搜索限于英语、法语、意大利语和西班牙语,时间范围为2000年1月1日至2024年8月30日。我们纳入了比较益生菌与安慰剂的随机对照试验(RCT)和观察性研究。我们排除了报告(1)益生元、合生元或后生元的研究,(2)动物研究,以及(3)病例报告、评论或综述。两名独立的评审员进行质量评估和数据提取。本荟萃分析根据PRISMA 2020和AMSTAR 2指南进行。主要结局指标是益生菌与安慰剂干预后的尿酸水平“前后”对比。森林图使用随机模型汇总数据。

结果

9项研究纳入了394例患者,其中201例接受益生菌治疗,193例接受安慰剂治疗。在主要结局指标方面,与对照组相比,益生菌组有统计学显著差异。然而,观察到存在显著异质性,(在应用亚组分析和Meta回归后)由以下因素解释:大洲、患病/健康、男性以及单一菌株益生菌。

结论

本荟萃分析表明,益生菌可降低患有疾病且接受单一菌株益生菌治疗的亚洲男性的尿酸水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/a47d6c1f716f/nutrients-17-02467-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/f0b1ef91a516/nutrients-17-02467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/3e7a318e2a81/nutrients-17-02467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/f04cb8c3e295/nutrients-17-02467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/46261d15e72e/nutrients-17-02467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/38bedbdf7950/nutrients-17-02467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/c169cf5ee324/nutrients-17-02467-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/a47d6c1f716f/nutrients-17-02467-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/f0b1ef91a516/nutrients-17-02467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/3e7a318e2a81/nutrients-17-02467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/f04cb8c3e295/nutrients-17-02467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/46261d15e72e/nutrients-17-02467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/38bedbdf7950/nutrients-17-02467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/c169cf5ee324/nutrients-17-02467-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e8/12348837/a47d6c1f716f/nutrients-17-02467-g007.jpg

相似文献

1
Effect of Probiotics on Uric Acid Levels: Meta-Analysis with Subgroup Analysis and Meta-Regression.益生菌对尿酸水平的影响:亚组分析和Meta回归的Meta分析
Nutrients. 2025 Jul 29;17(15):2467. doi: 10.3390/nu17152467.
2
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2011 Nov 9(11):CD004827. doi: 10.1002/14651858.CD004827.pub3.
3
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
4
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.益生菌预防儿童抗生素相关性腹泻
Cochrane Database Syst Rev. 2015 Dec 22(12):CD004827. doi: 10.1002/14651858.CD004827.pub4.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.益生菌用于预防成人和儿童艰难梭菌相关性腹泻
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
10
Probiotics for preventing urinary tract infections in adults and children.用于预防成人和儿童尿路感染的益生菌。
Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD008772. doi: 10.1002/14651858.CD008772.pub2.

本文引用的文献

1
Association between prebiotic, probiotic consumption and hyperuricemia in U.S. adults: a cross-sectional study from NHANES 2011-2018.美国成年人中益生元、益生菌摄入与高尿酸血症之间的关联:一项基于2011 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究
Front Nutr. 2025 Mar 14;12:1492708. doi: 10.3389/fnut.2025.1492708. eCollection 2025.
2
The relationship between serum uric acid and accelerated aging in middle-aged and older adults: a prospective cohort study based on CHARLS.中老年人群血清尿酸与加速衰老的关系:基于中国健康与养老追踪调查(CHARLS)的前瞻性队列研究
J Nutr Health Aging. 2025 Mar;29(3):100488. doi: 10.1016/j.jnha.2025.100488. Epub 2025 Jan 15.
3
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review.
理解肠道微生物群的复杂功能:其对肥胖及其他疾病发病机制的影响:综述
Diabetol Metab Syndr. 2024 Dec 23;16(1):308. doi: 10.1186/s13098-024-01561-z.
4
Tryptophan Metabolism-Regulating Probiotics Alleviate Hyperuricemia by Protecting the Gut Barrier Integrity and Enhancing Colonic Uric Acid Excretion.色氨酸代谢调节益生菌通过保护肠道屏障完整性和增强结肠尿酸排泄来缓解高尿酸血症。
J Agric Food Chem. 2024 Dec 4;72(48):26746-26761. doi: 10.1021/acs.jafc.4c07716. Epub 2024 Nov 20.
5
Host-derived alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides.内源性物质通过改善肠道微生物群落和水解酶介导的嘌呤核苷降解来缓解高尿酸血症。
Elife. 2024 Nov 7;13:e100068. doi: 10.7554/eLife.100068.
6
Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management.基线肠道微生物组作为益生菌辅助治疗痛风管理中反应预测生物标志物。
Pharmacol Res. 2024 Nov;209:107445. doi: 10.1016/j.phrs.2024.107445. Epub 2024 Oct 11.
7
Gut Microbiota in Patients Receiving Dialysis: A Review.接受透析患者的肠道微生物群:综述
Pathogens. 2024 Sep 15;13(9):801. doi: 10.3390/pathogens13090801.
8
Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study.益生菌发酵乳杆菌 TSF331、罗伊氏乳杆菌 TSR332 和植物乳杆菌 TSP05 改善肝功能和尿酸管理:一项初步研究。
PLoS One. 2024 Jul 24;19(7):e0307181. doi: 10.1371/journal.pone.0307181. eCollection 2024.
9
[Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].[尿酸代谢、尿酸转运体与排尿异常血症]
Yakugaku Zasshi. 2024;144(6):659-674. doi: 10.1248/yakushi.23-00217.
10
D2022 alleviates hyperuricemia and suppresses renal inflammation potential gut-kidney axis.D2022 可减轻高尿酸血症,并抑制肾脏炎症的潜在肠-肾轴。
Food Funct. 2024 Jun 4;15(11):6015-6027. doi: 10.1039/d4fo00118d.